Abstract
Convection-enhanced delivery (CED) of therapeutic agents is a promising local delivery technique that has been extensively studied as a treatment for CNS diseases over the last two decades. One continuing challenge of CED is accurate and consistent delivery of the agents to the target. The present study focused on a new type of therapeutic agent, NK012, a novel SN-38-loaded polymeric micelle. Local delivery profiles of NK012 and SN-38 were studied using rodent brain and intracranial rodent brain tumor models. First, the cytotoxicity of NK012 against glioma cell lines was determined in vitro. Proliferations of glioma cells were significantly reduced after exposure to NK012. Then, the distribution and local toxicity after CED delivery of NK012 and SN-38 were evaluated in vivo. Volume of distribution of NK012 after CED was much larger than that of SN-38. Histological examination revealed minimum brain tissue damage in rat brains after delivery of 40 µg NK012 but severe damage with SN-38 at the same dose. Subsequently, the efficacy of NK012 delivered via CED was tested in 9L and U87MG rodent orthotopic brain tumor models. CED of NK012 displayed excellent efficacy in the 9L and U87MG orthotopic brain tumor models. Furthermore, NK012...Continue Reading
References
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·R H BoboE H Oldfield
Feb 9, 1999·Journal of Neurosurgery·M Y ChenE H Oldfield
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S FriedmanL L Miller
Jun 17, 1999·Advances and Technical Standards in Neurosurgery·Y SawamuraN de Tribolet
Apr 17, 2001·Neuro-oncology·D R Groothuis
May 9, 2002·Journal of Neuro-oncology·Marc C Chamberlain
Apr 2, 2003·Nature Medicine·Steven S GillPeter Heywood
Apr 25, 2003·Cancer·Timothy F CloughesyGary L Elfring
Apr 3, 2004·Cancer Research·Ryuta SaitoKrys S Bankiewicz
Oct 7, 2004·Cancer Research·Ryuta SaitoKrystof S Bankiewicz
Dec 2, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Grace H HuynhFrancis C Szoka
Feb 14, 2006·Journal of Neuroscience Methods·Ryuta SaitoKrystof S Bankiewicz
Mar 15, 2006·Neuro-oncology·Michael D PradosUNKNOWN North American Brain Tumor Consortium
Oct 19, 2006·Cancer Research·Fumiaki KoizumiYasuhiro Matsumura
Apr 11, 2008·Neurology·J L EberlingM J Aminoff
Aug 30, 2008·Neuro-oncology·Tomoo InoueTeiji Tominaga
Nov 4, 2008·Journal of Neurosurgery·Toshio KikuchiTeiji Tominaga
Feb 4, 2009·International Journal of Cancer. Journal International Du Cancer·Jun-ichiro KurodaYasuhiro Matsumura
Dec 22, 2009·Journal of Neurosurgery·John H SampsonUNKNOWN PRECISE Trial Investigators
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jun-ichiro KurodaYasuhiro Matsumura
Jun 1, 2010·Neuro-oncology·Sandeep KunwarUNKNOWN PRECISE Study Group
Jun 22, 2010·Advanced Drug Delivery Reviews·Yasuhiro Matsumura
Mar 12, 2013·Journal of Drug Delivery·Jonathan YunJeffrey N Bruce
Nov 26, 2013·Journal of Neuroscience Methods·Rong ZhangTeiji Tominaga
Citations
Aug 14, 2018·Journal of Drug Targeting·Feng YuYanyu Xiao
Nov 20, 2018·Nanomedicine·Fatemeh FarjadianMichael R Hamblin
May 28, 2020·Pharmaceutics·Yuan-Yun TsengShih-Jung Liu
Dec 17, 2020·Pharmaceutics·Jessica I GriffithWilliam F Elmquist
Oct 9, 2020·Advanced Drug Delivery Reviews·Aroa Duro-CastanoGiuseppe Battaglia
Apr 14, 2019·Trends in Pharmacological Sciences·Hélène LajousEmmanuel Garcion
Jun 3, 2021·International Journal of Molecular Sciences·Tao-Chieh YangYuan-Yun Tseng